Pluri Inc.
Israeli company engaged in the development of human placental adherent stromal cells for commercial use
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.
Nº Q7205567 ★★★
Rare · Organizations
Pluri Inc.
Israeli company engaged in the development of human placental adherent stromal cells for commercial use
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.
Last price
—
Floor price
—
7-day median
—
30-day sales
0
30-day range
—
In circulation
0
Price history
median
low – high
sales
No sales in this period
Show table
| Date | median | Low | High | sales |
|---|
Sales history
- Last sale
- —
- 30-day average
- —
- 30-day low
- —
- 30-day high
- —
- Sales 7d
- 0
- Sales 30d
- 0
No sales yet.
Anonymous sales: no buyer or seller shown. Figures count player-to-player sales only.
From Wikipedia
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.
Text: Wikipédia, CC BY-SA 4.0. · Image: מעיין בן דרור (CC BY-SA 4.0) ·
Related cards
Protalix BioTherapeutics
Israeli pharmaceutical company
Nº Q7251166 ★★★
Altos Labs
American biotechnology company
Nº Q110701976 ★
Plasson
Israeli company
Nº Q2144952 ★★★
Chromagen
Israeli company
Nº Q16340297 ★★★
Frutarom
Company
Nº Q909105 ★
IDE Technologies
Israeli company
Nº Q19878963 ★★★